RIL
JAZZ icon

Rothschild Investment LLC’s Jazz Pharmaceuticals JAZZ Stock Holding History

Rothschild Investment LLC’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.5M Buy
6,237
+5,354
+606% +$1.17M 0.06% 312
2026
Q1 		$167K Buy
883
+837
+1,820% +$146K 0.01% 724
2025
Q4 		$7.82K Buy
46
+20
+77% +$3.07K ﹤0.01% 1673
2025
Q3 		$3.43K Buy
26
+21
+420% +$2.52K ﹤0.01% 1903
2025
Q2 		$531 Buy
+5
New +$543 ﹤0.01% 2723

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Rothschild Investment LLC's JAZZ Position: Q2 2026 in Review

Rothschild Investment LLC increased its Jazz Pharmaceuticals (JAZZ) stake by 606% in Q2 2026, buying an estimated $1.17M and bringing the position to 6,237 shares worth $1.5M. The position accounts for 0.06% of the portfolio, ranked #312.

Rothschild Investment LLC first reported a position in JAZZ in Q2 2025 and has held it in 5 quarters since. 591 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Rothschild Investment LLC held 6,237 shares of Jazz Pharmaceuticals worth $1.5M as of Q2 2026.
  • Rothschild Investment LLC bought 5,354 Jazz Pharmaceuticals shares in Q2 2026, an estimated $1.17M.
  • Jazz Pharmaceuticals made up 0.06% of Rothschild Investment LLC's portfolio in Q2 2026, its #312 holding.
  • Rothschild Investment LLC first reported a position in Jazz Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 591 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.